Pharmaceutical Product Development Acquisitions and Exits, 11 Deals Between 2008 and 2019
healthcare services Company

Pharmaceutical Product Development has acquired 9 companies of its own, including 2 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 2 assets.

Pharmaceutical Product Development’s largest acquisition to date was in 2016, when it acquired Synexus for $274M. It’s largest disclosed sale occurred in 2009, when it sold Piedmont Research Center to Charles River Laboratories International for $46M. Pharmaceutical Product Development has acquired in 4 different US states, and 4 countries. The Company’s most targeted sectors include life science (78%) and information technology (23%).

Join Mergr and gain access to Pharmaceutical Product Development’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the healthcare services sector.

Pharmaceutical Product Development LLC

929 North Front Street,
Wilmington, North Carolina 28401-3331
United States,
(910) 251-0081

Pharmaceutical Product Development, Inc. ("PPDI") is a global contract research organization ("CRO") providing drug discovery, development and lifecycle management services. Its clients and partners primarily include pharmaceutical and biotechnology companies, in addition to medical device companies, academic institutions and government organizations. With offices in 44 countries and more than 11,000 professionals worldwide, PPDI applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments.

M&A Summary

Buy vs Sell

Year ≤ '14 '15 '16 '17 '18 '19 T
Buy (0.4/yr) # 7 - 2 - - - 9
vol $77M $274M $351M
Sell (0.2/yr) # 1 - - - - 1 2
vol $46M $46M

Top M&A Advisors

Financial Deals
Join to Access.
Legal Deals
Join to Access.

Deal Values

> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Synexus Ltd.
$274M (2016-06-06)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View
Largest Piedmont Research Center LLC
$46M (2009-04-03)

Healthcare Services M&A - Last 3 Years

Pharmaceutical Product Development was acquired by Hellman & Friedman And The Carlyle Group on December 4, 2011.

When analyzing the healthcare services sector as a whole, according to Mergr, in the last 3 years, there are 388 healthcare services companies that have made at least 1 acquisition, 32 have acquired at least 5 companies, and 7 have acquired more than 10 companies.

The most prolific strategic healthcare services acquirer over the past 3 years is MEDNAX, with 17 acquisitions. The most prolific private equity acquirer in the healthcare services sector over the past 3 years is KKR & Co. L.P. with 7 platform acquisitions.

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.8K Private Equity Firms
  • 133K M&A Transactions
  • 142K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.0K M&A Advisors
    (Investment Banks and Law Firms)
  • 37K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.